Back to Search Start Over

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

Authors :
Dimopoulos, Meletios
Spencer, Andrew
Attal, Michael
Prince, Miles H.
Harousseau, Jean-Luc
Dmoszynska, Anna
Miguel, Jesus San
Hellmann, Andrzej
Facon, Thierry
Foa, Robin
Corso, Alessandro
Masliak, Zvenyslava
Olesnyckyj, Marta
Zhinuan Yu
Patin, John
Zeldis, Jerome B.
Knight, Robert D.
Source :
The New England Journal of Medicine. Nov 22, 2007, Vol. 357 Issue 21, p2123, 10 p.
Publication Year :
2007

Abstract

The efficacy for lenalidomide plus dexamethasone in the treatment of relapsed or refractory multiple myeloma is determined. Lenalidomide plus dexamethasone is found to be better than high-dose dexamethasone alone.

Subjects

Subjects :
Drug therapy, Combination -- Health aspects
Multiple myeloma -- Drug therapy
Dexamethasone -- Health aspects
Dexamethasone -- Comparative analysis

Details

Language :
English
ISSN :
00284793
Volume :
357
Issue :
21
Database :
Gale General OneFile
Journal :
The New England Journal of Medicine
Publication Type :
Academic Journal
Accession number :
edsgcl.172080529

Tools

Authors Abstract Subjects Details